Roche gets USFDA nod for CINtec PLUS Cytology test for cervical cancer Medical Dialogues Bureau12 March 2020 12:12 PM ISTCINtec PLUS Cytology provides definitive information about which HPV-positive women may benefit most from immediate referral to colposcopy versus...
Sami Labs appoints Neeraja Shetty as CEO Medical Dialogues Bureau12 March 2020 9:00 AM ISTBangalore: Sami-Sabinsa Group, has announced the appointment of Ms Neeraja Shetty as the Chief Executive Officer of Sami Labs (a part of Sami-Sabinsa...
Torrent Pharma gets shareholder nod to raise up to Rs 5,000 crores Medical Dialogues Bureau11 March 2020 3:30 PM ISTNew Delhi: Torrent Pharmaceuticals has said it has received shareholders'' nod to raise up to Rs 5,000 crore through various instruments, including...
USFDA completes inspection of Natco's Kothur formulation facility Medical Dialogues Bureau11 March 2020 1:07 PM ISTHyderabad: Natco Pharma Limited has announced the completion of a Pre-approval inspection from the United States Food and Drug Administration (USFDA)...
Coronavirus: 5 medical stores license cancelled for selling masks, sanitisers at inflated rates Medical Dialogues Bureau11 March 2020 12:28 PM ISTRaids were conducted under the aegis of additional city magistrate (ACM) upon the instruction of the district magistrate (DM).
FDA, FTC Warn Seven Companies Selling Fraudulent Products to Treat COVID-19 Medical Dialogues Bureau11 March 2020 11:00 AM ISTThe FDA and FTC jointly issued warning letters to Vital Silver, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, GuruNanda,...
Zydus, XOMA enter into licensing agreement for IL-2-Based Immuno-Oncology Therapy Medical Dialogues Bureau11 March 2020 9:00 AM ISTAhmedabad, Emeryville: Zydus Cadila and XOMA Corporation have announced they have entered into a licensing agreement to advance an IL-2-based...
CDSCO updates FAQs Drugs & Clinical Trial Rules 2019 MD bureau10 March 2020 1:50 PM ISTNew Delhi: Aimed at promoting clinical research in the country. Union Health Ministry notified the Drugs and Clinical Trials Rules, 2019 in the month...
USFDA Accepts Biocon, Mylan's application for review of Proposed Biosimilar of Bevacizumab Medical Dialogues Bureau10 March 2020 1:15 PM ISTBiocon Ltd. and Mylan N.V. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application (BLA)...
AstraZeneca fails to meet target endpoints in Phase II bladder cancer trial Medical Dialogues Bureau10 March 2020 9:30 AM ISTUSA: The Phase III DANUBE trial for Imfinzi (durvalumab) and Imfinzi plus tremelimumab in unresectable, Stage IV (metastatic) bladder cancer did not...
Biogen, Sangamo collaborate for gene regulation therapies in neurological ailments Medical Dialogues Bureau10 March 2020 9:00 AM ISTBiogen has exclusive global rights to ST-501 for tauopathies including Alzheimer's disease, ST-502 for synucleinopathies including Parkinson's...
Urovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladder Medical Dialogues Bureau9 March 2020 12:26 PM ISTIRVINE -Urovant Sciences has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application...
